S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
Buy THIS stock before Taiwan is attacked (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Buy THIS stock before Taiwan is attacked (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
UK Treasury chief says he'll hike the minimum wage but rules out tax cuts while inflation stays high
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
Buy THIS stock before Taiwan is attacked (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Buy THIS stock before Taiwan is attacked (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
UK Treasury chief says he'll hike the minimum wage but rules out tax cuts while inflation stays high
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
Buy THIS stock before Taiwan is attacked (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Buy THIS stock before Taiwan is attacked (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
UK Treasury chief says he'll hike the minimum wage but rules out tax cuts while inflation stays high
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
Buy THIS stock before Taiwan is attacked (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Buy THIS stock before Taiwan is attacked (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
UK Treasury chief says he'll hike the minimum wage but rules out tax cuts while inflation stays high
NASDAQ:RCEL

AVITA Medical (RCEL) Stock Forecast, Price & News

$14.61
+0.03 (+0.21%)
(As of 09/29/2023 08:53 PM ET)
Compare
Today's Range
$14.35
$14.81
50-Day Range
$13.84
$20.79
52-Week Range
$4.41
$21.70
Volume
251,900 shs
Average Volume
196,484 shs
Market Capitalization
$372.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$28.40

AVITA Medical MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
94.4% Upside
$28.40 Price Target
Short Interest
Bearish
3.80% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.60mentions of AVITA Medical in the last 14 days
Based on 4 Articles This Week
Insider Trading
Acquiring Shares
$89,650 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($1.50) to ($1.30) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.94 out of 5 stars

Medical Sector

689th out of 970 stocks

Surgical & Medical Instruments Industry

76th out of 99 stocks


RCEL stock logo

About AVITA Medical (NASDAQ:RCEL) Stock

AVITA Medical, Inc. operates as a regenerative medicine company in the United States, Australia, Japan, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's skin. Its lead product is RECELL System, a platform technology allows for the preparation and delivery of spray-on skin cells to regenerate natural healthy epidermis, as well as to use in the treatment of acute thermal burns in patients eighteen years and older. AVITA Medical, Inc. has a research agreement with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

RCEL Price History

RCEL Stock News Headlines

Elon Did It Again: This Could be Bigger than Tesla
Love him or hate him, it’s hard to deny Elon Musk is a genius. After revolutionizing online payment processing (PayPal), space exploration (SpaceX), and the auto industry (Tesla)... He’s getting ready to do it again with his new AI venture.
Avita Medical (ASX: AVH)
5 Best Cosmetic Surgery and Aesthetics Stocks to Buy
Elon Did It Again: This Could be Bigger than Tesla
Love him or hate him, it’s hard to deny Elon Musk is a genius. After revolutionizing online payment processing (PayPal), space exploration (SpaceX), and the auto industry (Tesla)... He’s getting ready to do it again with his new AI venture.
Expert Ratings for AVITA Medical
Avita Medical (RCEL) Earnings Dates & Reports
AVITA Medical Reports Second Quarter Financial Results
Piper Sandler Remains a Buy on Avita Medical (RCEL)
See More Headlines
Receive RCEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AVITA Medical and its competitors with MarketBeat's FREE daily newsletter.

RCEL Company Calendar

Last Earnings
8/10/2023
Today
10/01/2023
Next Earnings (Estimated)
11/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:RCEL
Fax
N/A
Employees
126
Year Founded
2008

Price Target and Rating

Average Stock Price Forecast
$28.40
High Stock Price Forecast
$40.00
Low Stock Price Forecast
$23.00
Forecasted Upside/Downside
+94.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$-26,670,000.00
Pretax Margin
-74.60%

Debt

Sales & Book Value

Annual Sales
$34.42 million
Book Value
$3.39 per share

Miscellaneous

Free Float
24,979,000
Market Cap
$372.26 million
Optionable
Not Optionable
Beta
1.49

Social Links

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. James M. Corbett (Age 65)
    CEO, Pres & Exec. Director
    Comp: $787.1k
  • Mr. Andrew Quick (Age 52)
    Chief Technology Officer
    Comp: $615.86k
  • Ms. Donna Shiroma (Age 61)
    Gen. Counsel & Sec.
    Comp: $642.72k
  • Mr. David O'Toole
    Chief Financial Officer
  • Mr. David Fencil
    Sr. VP of Global Operations
  • Ms. Jessica Ekeberg
    Investor Relations Exec.
  • Ms. Debbie Garner
    Sr. VP of Global Marketing & Strategy
  • Mr. Rob Hall
    Sr. VP of HR
  • Mr. Terry Bromley
    Sr. VP of Global Sales
  • Dr. Niraj Doshi J.D.
    P.M.P., Ph.D., Sr. VP of Product Devel. & Program Management













RCEL Stock - Frequently Asked Questions

Should I buy or sell AVITA Medical stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AVITA Medical in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" RCEL shares.
View RCEL analyst ratings
or view top-rated stocks.

What is AVITA Medical's stock price forecast for 2023?

5 brokers have issued twelve-month price objectives for AVITA Medical's shares. Their RCEL share price forecasts range from $23.00 to $40.00. On average, they predict the company's stock price to reach $28.40 in the next twelve months. This suggests a possible upside of 94.4% from the stock's current price.
View analysts price targets for RCEL
or view top-rated stocks among Wall Street analysts.

How have RCEL shares performed in 2023?

AVITA Medical's stock was trading at $6.60 at the beginning of 2023. Since then, RCEL shares have increased by 121.4% and is now trading at $14.61.
View the best growth stocks for 2023 here
.

When is AVITA Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our RCEL earnings forecast
.

How were AVITA Medical's earnings last quarter?

AVITA Medical, Inc. (NASDAQ:RCEL) announced its quarterly earnings results on Thursday, August, 10th. The company reported ($0.41) EPS for the quarter, missing the consensus estimate of ($0.34) by $0.07. The business earned $11.75 million during the quarter, compared to the consensus estimate of $11.20 million. AVITA Medical had a negative net margin of 74.77% and a negative trailing twelve-month return on equity of 38.31%.

What guidance has AVITA Medical issued on next quarter's earnings?

AVITA Medical issued an update on its second quarter 2023 earnings guidance on Thursday, August, 10th. The company provided EPS guidance of for the period. The company issued revenue guidance of $13.00 million-$14.00 million, compared to the consensus revenue estimate of $12.98 million.

What other stocks do shareholders of AVITA Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AVITA Medical investors own include NVIDIA (NVDA), Block (SQ), Alibaba Group (BABA), Micron Technology (MU), Netflix (NFLX), PayPal (PYPL), Twilio (TWLO), AbbVie (ABBV), Inovio Pharmaceuticals (INO) and Livongo Health (LVGO).

What is AVITA Medical's stock symbol?

AVITA Medical trades on the NASDAQ under the ticker symbol "RCEL."

How do I buy shares of AVITA Medical?

Shares of RCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AVITA Medical's stock price today?

One share of RCEL stock can currently be purchased for approximately $14.61.

How much money does AVITA Medical make?

AVITA Medical (NASDAQ:RCEL) has a market capitalization of $372.26 million and generates $34.42 million in revenue each year. The company earns $-26,670,000.00 in net income (profit) each year or ($1.21) on an earnings per share basis.

How many employees does AVITA Medical have?

The company employs 126 workers across the globe.

How can I contact AVITA Medical?

AVITA Medical's mailing address is 28159 Avenue Stanford Suite 220, Valencia CA, 91355. The official website for the company is www.avitamedical.com. The company can be reached via phone at (833) 462-8482 or via email at investor@avitamedical.com.

This page (NASDAQ:RCEL) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -